Summary
Clomethiazole (CLOM) is known to be an anti-convulsant drug and has been also reported to decrease serum prolactin (PRL) in humans. Both effects may be mediated by an enhancement of gabaergic transmission. In order to determine if (CLOM) interacts with GABA metabolism and/or at the GABA receptor level, we studied its effect on PRL release and on the binding of various compounds that interact with the GABAA-benzodiazepine-receptor complex. Intraperitoneal (IP) administration of CLOM to rats significantly decreased PRL levels, and this effect was antagonized by IP administration of bicuculline, an antagonist of the GABAA receptor. In vitro, the inhibitory effect of muscimol on PRL release from rat hemiadenohypophysis was potentiated in a dose-dependent manner by preincubation with CLOM. This effect was antagonized by picrotoxin (10−6 M). On the other hand, CLOM had no effect on GABA metabolism and did not compete with GABAA, GABAB or benzodiazepine binding sites in cortical membranes. GLOM competed, however, with the picrotoxin binding site labelled with [35S]-butylbicyclophosphoro-thionate (TBPS), at an IC50 value of 1.2 × 10−4 M, which is in the same range as some barbiturates. These results concerning PRL release and binding experiments with cortical membranes suggest that GLOM interacts with the picrotoxin/barbiturate site of the GABAA-receptor-chloride channel complex.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson RA, Mitchell R (1986) Distribution of Gaba binding site subtypes in rat pituitary gland. Brain Res 365:78–84
Charonnat R, Lechat P, Chareton J (1957) Sur les propriétés pharmacodynamiques d'un derive thiazolique. Thérapie 12:68–71
Clemens JA, Shaar CJ, Smaltig EB (1980) Dopamine, PIF and other regulators of prolactin secretion. Fed Proc 39:2907–2911
Enjalbert A, Ruberg S, Arancibia L, Fiore L, Priam M, Kordon C (1979) Independent inhibition of prolactin secretion by dopamine and γ-aminobutyric acid in vitro. Endocrinology 105:823 -826
Enna SJ, Snyder SM (1976) A simple, sensitive and specific radioreceptor assay for endogenous Gaba in brain tissue. J Neurochem 26:221
Frisch EP (1966) Chlormethiazole. Acta Psychiatr Scand (Suppl 192) 42:1–233
Grandison L, Guidotti A (1979) Gamma-aminobutyric acid receptor function in rat anterior pituitary: evidence for control of prolactin release. Endocrinology 105:754–759
Grandison L (1982) Suppression of prolactin secretion by benzodiazepines in vivo. Neuroendocrinology 34:369–373
Haefely W, Pole P, Schaffner R, Keller HH, Pieri L, Möhler H (1979) Facilitation of Gabaergic transmission by drugs. In: Krogsgaard-Larsen P, Scheel-Krüger J, Kofod H (eds) GABA neurotransmitters. Munksgaard, Copenhagen, pp 357–375
Hill DR, Bowery NG (1981) [3H]-Baclofen and [3H]-GABA bind to bicuculline insensitive GABAB sites in rat brain. Nature (Lond) 290:149–152
Leeb-Lundberg F, Showman A, Olsen RW (1981) Interactioon of anti-convulsants with the barbiturate benzodiazepine GABA receptor complex. Eur J Pharmacol 72:125–129
Lloyd KG, Vargas F (1982) [3H]Nipecotic acid: identification of GABA uptake sites in frozen tissue. In: Okada Y, Roberts E (eds) Problems in GABA research. From brain to bacteria. Excerpta Medica, pp 355–364
Locatelli V, Cocchi D, Frigerio D, Betti R, Krogsgaards-Larsen P, Racagni G, Muller EE (1979) Dual gamma aminobutyric acid control of prolactin secretion in the rat. Endocrinology 105:778–785
Macdonald RL, Barker JL (1979) Enhancement of GABA mediated post synaptic inhibition in cultured mammalian spinal cord neurons: a common mode of anticonvulsant action. Brain Res 167:323–327
Majumdar SK, Shaw GK, Thomson AD (1978) Effects of chlormethiazole on serum prolactin. Br Med J 2:1266–1267
Meldrum BS (1979) Convulsant drugs, antivonvulsants and GABA-mediated neuronal inhibition. In: Krogsgaard-Larsen P, Scheel-Kruger J, Kofod H (eds) GABA-neurotransmitters. Munksgaard, Copenhagen, pp 390–405
Möhler R, Okada T, Heitz P, Ulrich J (1978) Biochemical identification of the sites of action of benzodiazepines in human brain by [3H]-diazepam binding. Life Sci 22:985–995
Niswender GD, Chen CL, Midgley AR, Ellis J, Meites J (1969) Radioimmunoassay for rat prolactin. Proc Soc Exp Biol Med 130:793–799
Ögren SO (1986) Chlormethiazole, mode of action. Acta Psychiatr Scand (Suppl 329) 73:13–27
Olsen RW, Snowman AM (1982) Chloride dependent enhancement by barbiturate of gamma aminobutyric acid receptor binding. J Neurosci 2:1812–1823
Schally AV, Dupont A, Arimuka A, Takahara J, Redding TW, Clemens J, Shaar C (1976) Purification of a catecholamine rich fraction with prolactin-release inhibiting factor (PIF) activity from hypothalami. Acta Endocrinol 82:1–14
Schettini G, Cronin MJ, O'Dell SB, MacLeod RM (1984) The benzodiazepine agonist diazepam inhibits basal and secretagogue stimulated prolactin release in vitro. Brain Res 291: 343–349
Simmonds MA (1981) Distinction between the effects of barbiturate, receptor activation and antagonism by bicuculline and picrotoxin. Br J Pharmacol 73:739–747
Skolnick P, Paul SM, Barker J (1980) Pentobarbital potentiates GABA enhanced [3H]-diazepam binding to benzodiazepine receptors. Eur J Pharmacol 65:125–127
Skolnick P, Rice KC, Barker JL, Paul SM (1982) Interactions of barbiturates with benzodiazepine receptors in the central nervous system. Brain Res 233:143–146
Squires RF, Casida JE, Richardson M, Saederup E (1983)35[S] t. butylbicyclophosphorothionate binds with high affinity to brain specific sites coupled to γ-aminobutyric acid A and ion recognition site. Mol Pharmacol 23:326–336
Study RE, Barker JL (1981) Diazepam (−)pentobarbital fluctuation analysis reveals different mechanism for potentiation of aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci 78:7180–7184
Ticku MK, Olsen RW (1978) Interaction of barbiturate with dihydropicrotoxin binding sites to the GABA receptor ionophore system. Life Sci 22:1643 -1652
Ticku MK, Maksay G (1983) Convulsant/depressant site of action of the allosteric benzodiazepine-GABA receptor ionophore complex. Life Sci 33:2363–2375
Trifiletti RR, Snowman AM, Snyder SH (1985) Barbiturate recognition site on the GABA/benzodiazepine receptor complex is distinct from the picrotoxin TBPS recognition site. Eur J Pharmacol 106:441–447
Vincent RS, Hokfelt T, Wu JY (1982) GABA neurone system in hypothalamus and the pituitary gland. Neuroendocrinology 34:117–122
Wrong EHF, Snowman AM, Leeb-Lundberg LMF, Olsen RW (1984) Barbiturates allosterically inhibit GABA antagonist and benzodiazepine inverse agonist binding. Eur J Pharmacol 102:205–212
Zecca L, Zambotti F, Zonta N, Mantegazza P (1982) Determination of γ-aminobutytic acid in brain areas by high performance liquid chromatography of dansyl derivatives with ultra violet detection. J Chromatog 233:307–312
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vincens, M., Enjalbert, A., Lloyd, K.G. et al. Evidence that clomethiazole interacts with the macromolecular GABA A-receptor complex in the central nervous system and in the anterior pituitary gland. Naunyn-Schmiedeberg's Arch. Pharmacol. 339, 397–402 (1989). https://doi.org/10.1007/BF00736053
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00736053